Global Fund SR2020
Investigator: Starley Shade, PhD, MPH
Sponsor: Euro Health Group AS
Location(s): United States
The Strategic Review 2020 (SR 2020) will assess the outcome and impact of Global Fund investments in HIV, TB and malaria and in building resilient and sustainable systems for health. It will also assess the operationalization and implementation of the Global Fund Strategy 2017-2022 at its mid-term, provide lessons, and suggest approaches for strengthening implementation of the remainder of the strategy and for the development of the post-2022 Global Fund Strategy.